IP Library Granted Patent US 9,902,771
Granted Patent B2
US 9,902,771 · App. 14/971,536 · Granted Feb 27, 2018

Anti-5T4 antibodies and uses thereof

Inventors: Erwin R. Boghaert (Monroe, NY); Nitin K. Damle (Upper Saddle River, NJ); Philip Ross Hamann (Thiells, NY); Kiran Khandke (Nanuet, NY); Arthur Kunz (New City, NY); Kimberly A. Marquette (Somerville, MA); Lioudmila Tchistiakova (Andover, MA); Davinder Gill (Andover, MA); Sreekumar R. Kodangattil (Plainsboro, NJ)
Assignee: WYETH LLC
C07K16/28A61K47/6849A61K51/1027C07K14/82C07K16/30C07K16/32A61K2039/505C07K2317/24C07K2317/33C07K2317/34C07K2317/52C07K2317/56C07K2317/565C07K2317/77C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,902,771
App. No.
14/971,536
Granted
Feb 27, 2018
Kind
B2
Abstract

Anti-5T4 antibodies, anti-5T4 antibody/drug conjugates, and methods for preparing and using the same.

Claims (38)

1. An isolated nucleic acid comprising a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence of nucleotides 58-414 of SEQ ID NO: 1;

(b) a nucleotide sequence set forth as any one of SEQ ID NOs: 48, 50, 53, or 55;

(c) a nucleotide sequence encoding a heavy chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 49, 51, 52, 54, or 56;

(d) a nucleotide sequence of nucleotides 55-405 of SEQ ID NO: 5;

(e) a nucleotide sequence encoding a heavy chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 77 or 78;

(f) a nucleotide sequence of nucleotides 58-423 of SEQ ID NO: 9; and

(g) a nucleotide sequence encoding a heavy chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 81 or 82.

2. An isolated nucleic acid comprising a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence of nucleotides 61-381 of SEQ ID NO: 3;

(b) a nucleotide sequence set forth as any one of SEQ ID NOs: 57, 59, 61, 63, 65, 67, 69, 71, 73, or 75;

(c) a nucleotide sequence encoding a light chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 58, 60, 62, 64, 66, 68, 70, 72, 74, or 76,

(d) a nucleotide sequence of nucleotides 67-390 of SEQ ID NO: 7;

(e) a nucleotide sequence encoding a light chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 79 or 80;

(f) a nucleotide sequence of nucleotides 61-381 of SEQ ID NO: 11; and

(g) a nucleotide sequence encoding a light chain variable region having an amino acid sequence set forth as any one of SEQ ID NOs: 83 or 84.

3. The isolated nucleic acid of claim 1 , further comprising a nucleotide sequence encoding a human heavy chain constant region.

4. The isolated nucleic acid of claim 3 , wherein the human heavy chain constant region is a human IgG4 heavy chain constant region.

5. The isolated nucleic acid of claim 4 , wherein the human IgG4 heavy chain constant region has an amino acid sequence set forth as SEQ ID NO: 45.

6. The isolated nucleic acid of claim 3 , wherein the human heavy chain constant region is a human IgG1 heavy chain constant region.

7. The isolated nucleic acid of claim 6 , wherein the human IgG1 heavy chain constant region has an amino acid sequence set forth as SEQ ID NO: 46.

8. The isolated nucleic of claim 2 , further comprising a nucleotide sequence encoding a human light chain constant region.

9. The isolated nucleic acid of claim 8 , wherein the human light chain constant region is a human kappa light chain constant region.

10. The isolated nucleic acid of claim 9 , wherein human kappa light chain constant region has an amino acid sequence set forth as SEQ ID NO: 47.

11. A vector comprising the isolated nucleic acid of claim 1 .

12. A vector comprising the isolated nucleic acid of claim 2 .

13. The vector of claim 11 , further comprising the isolated nucleic acid of claim 2 .

14. The vector of claim 11 , comprising a nucleotide sequence set forth as SEQ ID NO: 53.

15. The vector of claim 12 , comprising a nucleotide sequence set forth as SEQ ID NO: 69.

16. The vector of claim 11 , further comprising a nucleotide sequence set forth as SEQ ID NO: 69.

17. The vector of claim 14 , further comprising a nucleotide sequence encoding a human IgG1 heavy chain constant region having an amino acid sequence set forth as SEQ ID NO: 46.

18. The vector of claim 15 , further comprising a nucleotide sequence encoding a human kappa light chain constant region having an amino acid sequence set forth as SEQ ID NO: 47.

19. The vector of claim 17 , further comprising a nucleotide sequence encoding a human kappa light chain constant region having an amino acid sequence set forth as SEQ ID NO: 47.

20. A vector comprising:

(a) an isolated nucleic acid comprising a nucleotide sequence encoding a heavy chain variable region having an amino acid sequence set forth as SEQ ID NO: 54;

(b) an isolated nucleic acid comprising a nucleotide sequence encoding a human IgG1 heavy chain constant region having an amino acid sequence set forth as SEQ ID NO: 46;

(c) an isolated nucleic acid comprising a nucleotide sequence encoding a light chain variable region having an amino acid sequence set forth as SEQ ID NO: 70; and

(d) an isolated nucleic acid comprising a nucleotide sequence encoding a human kappa light chain constant region having an amino acid sequence set forth as SEQ ID NO: 47.

Assignments (2)
CHANGE OF NAME Recorded Sep 25, 2017
From: WYETH
To: WYETH LLC
Reel/Frame 043990/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2017
From: BOGHAERT, ERWIN R.; DAMLE, NITIN K.; HAMANN, PHILIP ROSS; KHANDKE, KIRAN; KUNZ, ARTHUR; MARQUETTE, KIMBERLY A.; TCHISTIAKOVA, LIOUDMILA; GILL, DAVINDER; SREEKUMAR, KODANGATTIL R.
To: WYETH
Reel/Frame 043617/0966 →
Continuity (6)
Division 14290345 · May 29, 2014
Division 13208162 · Aug 11, 2011
Division 11684329 · Mar 9, 2007
Provisional Application 60891248 · Feb 23, 2007
Provisional Application 60781346 · Mar 10, 2006
Related Publication 20160185859A1 · Jun 30, 2016